Literature DB >> 18235220

Asymmetric localization of the CDC25B phosphatase to the mother centrosome during interphase.

Rose Boutros1, Bernard Ducommun.   

Abstract

The Cyclin-Dependent Kinase (CDK)-activating phosphatase CDC25B, localises to the centrosomes where its activity is both positively and negatively regulated by several kinases including Aurora A and CHK1. Our recent data also demonstrate a role for CDC25B in the centrosome duplication cycle and microtubule nucleation in interphase that appears to involve the recruitment of gamma-tubulin to the centrosomes. In the present study, we report that CDC25B, along with CHK1, CDK1 and WEE1, localize asymmetrically around the mother centrosome from S to G2-phases, and gradually become evenly distributed to the two centrosomes by late G2 phase, concomitant with centrosome maturation. We further demonstrate that siRNA inhibition of CDC25B results in an accumulation of cells in G2 phase with two separated centrosomes, each containing only a single centriole, suggesting a requirement for CDC25B in centriole duplication. We propose that the localisation of key cell cycle regulators to the mother centrosome ensures synchrony between the centrosome duplication and cell division cycles.

Mesh:

Substances:

Year:  2007        PMID: 18235220     DOI: 10.4161/cc.7.3.5295

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

Review 1.  Centrosomes in the DNA damage response--the hub outside the centre.

Authors:  Lisa I Mullee; Ciaran G Morrison
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

2.  Budding yeast Wee1 distinguishes spindle pole bodies to guide their pattern of age-dependent segregation.

Authors:  Jette Lengefeld; Manuel Hotz; Meaghen Rollins; Kristin Baetz; Yves Barral
Journal:  Nat Cell Biol       Date:  2017-07-17       Impact factor: 28.824

3.  Expression and clinical significance of Wee1 in colorectal cancer.

Authors:  Eivind Valen Egeland; Kjersti Flatmark; Jahn M Nesland; Vivi Ann Flørenes; Gunhild M Mælandsmo; Kjetil Boye
Journal:  Tumour Biol       Date:  2016-05-24

4.  CDC25B associates with a centrin 2-containing complex and is involved in maintaining centrosome integrity.

Authors:  Rose Boutros; Corinne Lorenzo; Odile Mondesert; Alain Jauneau; Vanessa Oakes; Christine Dozier; Brian Gabrielli; Bernard Ducommun
Journal:  Biol Cell       Date:  2011-02       Impact factor: 4.458

5.  DNA damage bypass operates in the S and G2 phases of the cell cycle and exhibits differential mutagenicity.

Authors:  Noam Diamant; Ayal Hendel; Ilan Vered; Thomas Carell; Thomas Reissner; Niels de Wind; Nicholas Geacinov; Zvi Livneh
Journal:  Nucleic Acids Res       Date:  2011-09-09       Impact factor: 16.971

6.  Kizuna is a novel mitotic substrate for CDC25B phosphatase.

Authors:  Yann Thomas; Marion Peter; Francisca Mechali; Jean-Marie Blanchard; Olivier Coux; Véronique Baldin
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 7.  An updated view on the centrosome as a cell cycle regulator.

Authors:  Muyang Lin; Shuang Shuang Xie; Kuan Yoow Chan
Journal:  Cell Div       Date:  2022-02-14       Impact factor: 5.130

8.  Evidence that human blastomere cleavage is under unique cell cycle control.

Authors:  Ann A Kiessling; Ritsa Bletsa; Bryan Desmarais; Christina Mara; Kostas Kallianidis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2009-03-14       Impact factor: 3.412

9.  Inhibition of PI3K/Akt pathway impairs G2/M transition of cell cycle in late developing progenitors of the avian embryo retina.

Authors:  Isis Moraes Ornelas; Thayane Martins Silva; Lucianne Fragel-Madeira; Ana Lucia Marques Ventura
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

10.  CDC25B overexpression stabilises centrin 2 and promotes the formation of excess centriolar foci.

Authors:  Rose Boutros; Odile Mondesert; Corinne Lorenzo; Puji Astuti; Grant McArthur; Megan Chircop; Bernard Ducommun; Brian Gabrielli
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.